Insider Trading Tracker: Live Industry - Biotech Stock Disclosures & Insider Buying from Jul 07, 2026 to Jul 21, 2026

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 200 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Elicio Therapeutics Inc	Robert Connelly	Director, CEO, President and Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	186,944	186,944	-		-	Stock Option (Right to Buy)
Elicio Therapeutics Inc	Christopher Haqq	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	64,643	64,643	-		-	Stock Option (Right to Buy)
Elicio Therapeutics Inc	Preetam Shah	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	60,833	60,833	-		-	Stock Option (Right to Buy)
Elicio Therapeutics Inc	Peter DeMuth	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	52,832	52,832	-		-	Stock Option (Right to Buy)
Vaxcyte Inc	John H. Markels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	23,029	23,029	-		-	Stock Option (right to buy)
Monte Rosa Therapeutics Inc	Markus Warmuth	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 23.18 per share.	16 Jul 2026	9,500	585,038	-	23.2	220,219	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share.	16 Jul 2026	8,300	53,472 (0%)	0%	146.0	1,212,049	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	8,300	80,740	-		-	Stock Option
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 534.21 per share.	16 Jul 2026	3,279	47,812 (0%)	0%	534.2	1,751,679	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 534.99 per share.	16 Jul 2026	1,519	45,252 (0%)	0%	535.0	812,648	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 535.88 per share.	16 Jul 2026	1,041	46,771 (0%)	0%	535.9	557,851	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 531.97 per share.	16 Jul 2026	861	51,891 (0%)	0%	532.0	458,025	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 532.94 per share.	16 Jul 2026	800	51,091 (0%)	0%	532.9	426,352	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 527.60 per share.	16 Jul 2026	600	52,872 (0%)	0%	527.6	316,557	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 529.81 per share.	16 Jul 2026	120	52,752 (0%)	0%	529.8	63,577	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 536.85 per share.	16 Jul 2026	80	45,172 (0%)	0%	536.9	42,948	Common Stock
Moderna	Stephen Hoge	President	Sale of securities on an exchange or to another person at price $ 67.60 per share.	15 Jul 2026	53,336	1,483,848 (0%)	0%	67.6	3,605,514	Common Stock
Moderna	Stephen Hoge	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share.	15 Jul 2026	37,226	1,521,074 (0%)	0%	19.2	712,878	Common Stock
Moderna	Stephen Hoge	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	37,226	0	-		-	Stock Option (Right to Buy)
Gain Therapeutics Inc	Dov A. Goldstein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	25,000	25,000	-		-	Stock Option (right to buy)
Gain Therapeutics Inc	Hans Peter Hasler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	25,000	25,000	-		-	Stock Option (right to buy)
Gain Therapeutics Inc	Claude Nicaise	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	25,000	25,000	-		-	Stock Option (right to buy)
Gain Therapeutics Inc	Khalid Islam	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	25,000	25,000	-		-	Stock Option (right to buy)
Gain Therapeutics Inc	Gwen A. Melincoff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	25,000	25,000	-		-	Stock Option (right to buy)
Moderna	Stephen Hoge	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	16,110	0	-		-	Stock Option (Right to Buy)
Moderna	Stephen Hoge	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share.	15 Jul 2026	16,110	1,537,184 (0%)	0%	19.2	308,507	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	15 Jul 2026	7,782	332,225 (0%)	0%	135.4	1,053,838	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	7,782	341,410	-		-	Stock Option
Monte Rosa Therapeutics Inc	Jennifer Champoux	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.98 per share.	15 Jul 2026	4,351	66,722	-	4.0	17,317	Common Stock
Monte Rosa Therapeutics Inc	Jennifer Champoux	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	4,351	26,947	-		-	Stock Option (Right to Buy)
Monte Rosa Therapeutics Inc	Jennifer Champoux	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 23.38 per share.	15 Jul 2026	4,351	62,371	-	23.4	101,730	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 531.97 per share.	15 Jul 2026	3,295	325,388 (0%)	0%	532.0	1,752,834	Common Stock
Gilead Sciences	Andrew D. Dickinson	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 129.93 per share.	15 Jul 2026	3,000	168,646 (0%)	0%	129.9	389,777	Common Stock
Gilead Sciences	Johanna Mercier	Chief Comm & Corp Aff Officer	Sale of securities on an exchange or to another person at price $ 129.92 per share.	15 Jul 2026	3,000	121,234 (0%)	0%	129.9	389,758	Common Stock
Anixa Biosciences Inc	Lewis H. Titterton	Director	Purchase of securities on an exchange or from another person at price $ 3.28 per share.	15 Jul 2026	2,797	974,967 (4%)	0%	3.3	9,174	Common Stock
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.14 per share.	15 Jul 2026	2,154	2,154	-	7.1	15,380	Common Stock
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	2,154	6,473	-		-	Stock Option (Right to Buy)
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	2,148	6,444	-		-	Stock Option (Right to Buy)
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.08 per share.	15 Jul 2026	2,148	4,302	-	9.1	19,504	Common Stock
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 150.25 per share.	15 Jul 2026	1,911	0	-	150.3	287,133	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	1,718	0	-		-	Stock Option
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	15 Jul 2026	1,718	42,231 (0%)	0%	135.4	232,652	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 531.03 per share.	15 Jul 2026	1,044	328,683 (0%)	0%	531.0	554,391	Common Stock
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 149.27 per share.	15 Jul 2026	1,029	1,911	-	149.3	153,595	Common Stock
Cg Oncology Inc	Leonard E. Post	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share.	15 Jul 2026	1,000	1,000	-	0.6	600	Common Stock
Cg Oncology Inc	Leonard E. Post	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	1,000	105,077	-		-	Director Stock Option (right to buy)
Cg Oncology Inc	Leonard E. Post	Director	Sale of securities on an exchange or to another person at price $ 71.17 per share.	15 Jul 2026	1,000	0	-	71.2	71,170	Common Stock
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 148.40 per share.	15 Jul 2026	840	2,940	-	148.4	124,658	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 533.08 per share.	15 Jul 2026	825	324,563 (0%)	0%	533.1	439,791	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 532.06 per share.	15 Jul 2026	800	40,713 (0%)	0%	532.1	425,647	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 529.03 per share.	15 Jul 2026	641	330,304 (0%)	0%	529.0	339,106	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 530.12 per share.	15 Jul 2026	577	329,727 (0%)	0%	530.1	305,878	Common Stock
Palvella Therapeutics Inc	Kathleen Goin	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 147.14 per share.	15 Jul 2026	522	3,780	-	147.1	76,805	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 524.40 per share.	15 Jul 2026	440	331,345 (0%)	0%	524.4	230,734	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 525.24 per share.	15 Jul 2026	280	331,065 (0%)	0%	525.2	147,066	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 530.97 per share.	15 Jul 2026	278	41,513 (0%)	0%	531.0	147,609	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 523.20 per share.	15 Jul 2026	203	331,785 (0%)	0%	523.2	106,210	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 521.84 per share.	15 Jul 2026	189	331,988 (0%)	0%	521.8	98,628	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 533.22 per share.	15 Jul 2026	160	40,553 (0%)	0%	533.2	85,315	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 529.67 per share.	15 Jul 2026	120	41,791 (0%)	0%	529.7	63,560	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 523.98 per share.	15 Jul 2026	120	42,031 (0%)	0%	524.0	62,877	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 527.77 per share.	15 Jul 2026	120	330,945 (0%)	0%	527.8	63,332	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 534.28 per share.	15 Jul 2026	120	324,443 (0%)	0%	534.3	64,113	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 525.42 per share.	15 Jul 2026	80	41,951 (0%)	0%	525.4	42,034	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 521.82 per share.	15 Jul 2026	80	42,151 (0%)	0%	521.8	41,746	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 520.92 per share.	15 Jul 2026	48	332,177 (0%)	0%	520.9	25,004	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 534.10 per share.	15 Jul 2026	40	40,513 (0%)	0%	534.1	21,364	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 527.55 per share.	15 Jul 2026	40	41,911 (0%)	0%	527.6	21,102	Common Stock
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.04 per share.	14 Jul 2026	16,250	16,250 (0%)	0%	3.0	49,400	Common Stock
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jul 2026	16,250	48,750	-		-	Stock option (right to buy)
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 5.13 per share.	14 Jul 2026	16,250	0 (0%)	0%	5.1	83,285	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	14 Jul 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Jul 2026	9,500	1,718	-		-	Stock Option
Apogee Therapeutics Inc	Carl Dambkowski	Chief Medical Officer	Gift of securities by or to the insider at price $ 0.00 per share.	14 Jul 2026	8,000	169,873	-		0	Common Stock
Rapport Therapeutics Inc	Abraham N. Ceesay	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 39.72 per share.	14 Jul 2026	5,481	542,546	-	39.7	217,715	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 526.13 per share.	14 Jul 2026	3,492	44,213 (0%)	0%	526.1	1,837,255	Common Stock
BioCardia Inc	Peter Altman	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.88 per share.	14 Jul 2026	2,800	366,885 (5%)	0%	0.9	2,464	Common Stock
Rapport Therapeutics Inc	Abraham N. Ceesay	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 40.57 per share.	14 Jul 2026	2,729	539,817	-	40.6	110,722	Common Stock
BioCardia Inc	Peter Altman	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.86 per share.	14 Jul 2026	1,500	368,385 (5%)	0%	0.9	1,290	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 525.16 per share.	14 Jul 2026	1,468	47,705 (0%)	0%	525.2	770,940	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 527.06 per share.	14 Jul 2026	1,220	42,993 (0%)	0%	527.1	643,010	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 529.21 per share.	14 Jul 2026	959	41,374 (0%)	0%	529.2	507,512	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 524.15 per share.	14 Jul 2026	840	49,173 (0%)	0%	524.1	440,284	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 528.13 per share.	14 Jul 2026	660	42,333 (0%)	0%	528.1	348,569	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 530.67 per share.	14 Jul 2026	554	40,820 (0%)	0%	530.7	293,993	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 532.60 per share.	14 Jul 2026	200	40,513 (0%)	0%	532.6	106,520	Common Stock
IQVIA Results Board Meeting	James A. Fasano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2026	195	6,268	-		-	Deferred Shares
IQVIA Results Board Meeting	Colleen A. Goggins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2026	183	5,297	-		-	Deferred Shares
IQVIA Results Board Meeting	John G. Danhakl	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2026	160	3,289	-		-	Deferred Shares
IQVIA Results Board Meeting	Leslie Wims Morris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jul 2026	148	6,784	-		-	Deferred Shares
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 531.08 per share.	14 Jul 2026	107	40,713 (0%)	0%	531.1	56,826	Common Stock
Disc Medicine Inc	John D. Quisel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share.	13 Jul 2026	25,584	251,648	-	9.9	252,258	Common Stock
Disc Medicine Inc	John D. Quisel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2026	25,584	15,791	-		-	Stock Option (Right to Buy)
Disc Medicine Inc	John D. Quisel	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 74.95 per share.	13 Jul 2026	16,896	232,464	-	74.9	1,266,303	Common Stock
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 27.58 per share.	13 Jul 2026	14,058	57,733	-	27.6	387,717	Common Stock
Mineralys Therapeutics Inc	Jon Congleton	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 27.24 per share.	13 Jul 2026	10,700	603,621	-	27.2	291,441	Common Stock
Disc Medicine Inc	John D. Quisel	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 74.27 per share.	13 Jul 2026	9,704	249,360	-	74.3	720,744	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	13 Jul 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2026	9,500	11,218	-		-	Stock Option
Disc Medicine Inc	John D. Quisel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.50 per share.	13 Jul 2026	7,416	259,064	-	13.5	100,116	Common Stock
Disc Medicine Inc	John D. Quisel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2026	7,416	124,586	-		-	Stock Option (Right to Buy)
Disc Medicine Inc	John D. Quisel	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 76.05 per share.	13 Jul 2026	6,400	226,064	-	76.1	486,733	Common Stock
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2026	6,349	0	-		-	Stock Option
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 26.61 per share.	13 Jul 2026	6,349	51,384	-	26.6	168,955	Common Stock
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share.	13 Jul 2026	6,349	71,791	-	1.1	6,857	Common Stock
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2026	4,167	79,167	-		-	Stock Option
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.25 per share.	13 Jul 2026	4,167	65,442	-	14.3	59,380	Common Stock
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2026	3,542	109,792	-		-	Stock Option
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.20 per share.	13 Jul 2026	3,542	61,275	-	10.2	36,128	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 534.63 per share.	13 Jul 2026	2,272	46,721 (0%)	0%	534.6	1,214,669	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 536.52 per share.	13 Jul 2026	2,223	42,307 (0%)	0%	536.5	1,192,674	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 535.47 per share.	13 Jul 2026	2,191	44,530 (0%)	0%	535.5	1,173,213	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 533.70 per share.	13 Jul 2026	1,020	48,993 (0%)	0%	533.7	544,376	Common Stock
Natera Inc	Jonathan Sheena	Director, CO-FOUNDER	Sale of securities on an exchange or to another person at price $ 264.30 per share.	13 Jul 2026	800	248,052 (0%)	0%	264.3	211,436	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 537.66 per share.	13 Jul 2026	665	41,642 (0%)	0%	537.7	357,545	Common Stock
ANI Pharma Inc	Meredith W. Cook	SR. VP, GENERAL COUNSEL & SEC.	Sale of securities on an exchange or to another person at price $ 81.84 per share.	13 Jul 2026	500	77,390 (0%)	0%	81.8	40,920	Common Stock
Natera Inc	Jonathan Sheena	Director, CO-FOUNDER	Sale of securities on an exchange or to another person at price $ 268.39 per share.	13 Jul 2026	500	246,202 (0%)	0%	268.4	134,194	Common Stock
Natera Inc	Jonathan Sheena	Director, CO-FOUNDER	Sale of securities on an exchange or to another person at price $ 266.75 per share.	13 Jul 2026	500	247,152 (0%)	0%	266.8	133,377	Common Stock
Natera Inc	Jonathan Sheena	Director, CO-FOUNDER	Sale of securities on an exchange or to another person at price $ 262.72 per share.	13 Jul 2026	500	248,852 (0%)	0%	262.7	131,358	Common Stock
Natera Inc	Jonathan Sheena	Director, CO-FOUNDER	Sale of securities on an exchange or to another person at price $ 267.72 per share.	13 Jul 2026	450	246,702 (0%)	0%	267.7	120,475	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 538.60 per share.	13 Jul 2026	409	41,233 (0%)	0%	538.6	220,289	Common Stock
Natera Inc	Jonathan Sheena	Director, CO-FOUNDER	Sale of securities on an exchange or to another person at price $ 265.15 per share.	13 Jul 2026	400	247,652 (0%)	0%	265.2	106,060	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 541.10 per share.	13 Jul 2026	360	40,553 (0%)	0%	541.1	194,796	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 539.60 per share.	13 Jul 2026	320	40,913 (0%)	0%	539.6	172,673	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 542.80 per share.	13 Jul 2026	40	40,513 (0%)	0%	542.8	21,712	Common Stock
Taysha Gene Therapies Inc	Sukumar Nagendran	Director, President and Head of R&D	Sale of securities on an exchange or to another person at price $ 6.24 per share.	10 Jul 2026	200,000	936,410	-	6.2	1,248,000	Common Stock
C4 Therapeutics Inc	Leonard M.J. Reyno	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jul 2026	15,325	379,803	-		0	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	10 Jul 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jul 2026	9,500	20,718	-		-	Stock Option
C4 Therapeutics Inc	Leonard M.J. Reyno	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.06 per share.	10 Jul 2026	7,397	372,406	-	4.1	30,032	Common Stock
Anixa Biosciences Inc	Amit Kumar	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 3.04 per share.	10 Jul 2026	5,000	635,812 (3%)	0%	3.0	15,200	Common Stock
Agenus Inc	Garo H. Armen	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 3.35 per share.	10 Jul 2026	4,852	371,108 (0%)	0%	3.3	16,254	Common Stock
Neurocrine Biosciences Inc	Ingrid Delaet	Chief Regulatory Officer	Sale of securities on an exchange or to another person at price $ 181.02 per share.	10 Jul 2026	4,367	16,225 (0%)	0%	181.0	790,514	Common Stock
Neurocrine Biosciences Inc	Ingrid Delaet	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jul 2026	4,367	0	-		-	Non-Qualified Stock Option
Neurocrine Biosciences Inc	Ingrid Delaet	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.02 per share.	10 Jul 2026	4,367	20,592 (0%)	0%	106.0	462,989	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 542.49 per share.	10 Jul 2026	1,870	46,573 (0%)	0%	542.5	1,014,451	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 547.17 per share.	10 Jul 2026	1,578	40,993 (0%)	0%	547.2	863,440	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 545.54 per share.	10 Jul 2026	1,524	44,009 (0%)	0%	545.5	831,409	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 546.42 per share.	10 Jul 2026	1,438	42,571 (0%)	0%	546.4	785,750	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 541.47 per share.	10 Jul 2026	970	48,443 (0%)	0%	541.5	525,226	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 543.34 per share.	10 Jul 2026	676	45,897 (0%)	0%	543.3	367,296	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 540.37 per share.	10 Jul 2026	600	49,413 (0%)	0%	540.4	324,223	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 548.44 per share.	10 Jul 2026	400	40,593 (0%)	0%	548.4	219,375	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 544.54 per share.	10 Jul 2026	364	45,533 (0%)	0%	544.5	198,212	Common Stock
Elanco Animal Health Inc	Jeffrey N. Simmons	Director, PRESIDENT, CEO AND DIRECTOR	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jul 2026	113	24,770	-		-	Deferred Stock Units
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 553.48 per share.	10 Jul 2026	80	40,513 (0%)	0%	553.5	44,278	Common Stock
Elanco Animal Health Inc	Rajeev A. Modi	SEE REMARKS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jul 2026	59	9,582	-		-	Deferred Stock Units
Elanco Animal Health Inc	Robert M. VanHimbergen	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jul 2026	7	116	-		-	Deferred Stock Units
Cue Biopharma Inc	Shao-Lee Lin	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	327,537	655,074 (2%)	1%		0	Common Stock
Cue Biopharma Inc	Shao-Lee Lin	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	327,537	327,537	-		-	Common Stock
Traws Pharma Inc 10-year low	Iain D. Dukes	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	274,000	274,000	-		-	Stock Option (right to buy)
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.00 per share.	09 Jul 2026	112,422	139,805 (0%)	0%	29	3,260,238	Common Stock
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Sale of securities on an exchange or to another person at price $ 90.00 per share.	09 Jul 2026	112,422	8,383 (0%)	0%	90	10,117,980	Common Stock
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	112,422	0	-		-	Stock Option (Right to Buy)
Traws Pharma Inc 10-year low	Charles David Pauza	Chief Science Officer Virology	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	97,000	97,000	-		-	Stock Option (right to buy)
Traws Pharma Inc 10-year low	Nikolay Savchuk	Director, Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	93,000	93,000	-		-	Stock Option (right to buy)
Traws Pharma Inc 10-year low	Charles Parker	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	90,000	90,000	-		-	Stock Option (right to buy)
Traws Pharma Inc 10-year low	Robert R Redfield	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	84,000	84,000	-		-	Stock Option (right to buy)
Pliant Therapeutics Inc	Robert Iannone	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	60,000	60,000	-		-	Stock Option (Right to Buy)
Pliant Therapeutics Inc	Flavia Borellini	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	60,000	60,000	-		-	Stock Option (Right to Buy)
Cue Biopharma Inc	Sumita Ray	Chief Legal Compliance Officer, Corporate Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	54,589	54,589	-		-	Common Stock
Cue Biopharma Inc	Sumita Ray	Chief Legal Compliance Officer, Corporate Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	54,589	109,178 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Juan Carlos Jaen	President	Sale of securities on an exchange or to another person at price $ 30.05 per share.	09 Jul 2026	48,502	842,307 (1%)	0%	30.1	1,457,631	Common Stock
4D Molecular Therapeutics Inc	David Kirn	Director, See Remarks	Sale of securities on an exchange or to another person at price $ 12.87 per share.	09 Jul 2026	42,608	899,877	-	12.9	548,177	Common Stock
Cue Biopharma Inc	Michael Meluzio	VP, Prin. Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	40,942	40,942 (0%)	0%		0	Common Stock
Cue Biopharma Inc	Michael Meluzio	VP, Prin. Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	40,942	40,942	-		-	Common Stock
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Sale of securities on an exchange or to another person at price $ 84.00 per share.	09 Jul 2026	36,167	120,805 (0%)	0%	84	3,038,028	Common Stock
Dianthus Therapeutics Inc 10-year high	Ryan Savitz	EVP, CFO & CBO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.77 per share.	09 Jul 2026	31,249	31,249	-	21.8	680,291	Common Stock
Dianthus Therapeutics Inc 10-year high	Ryan Savitz	EVP, CFO & CBO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	31,249	68,751	-		-	Stock Option (Right to Buy)
Cue Biopharma Inc	Daniel A. Camardo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	21,800	21,800 (0%)	0%		0	Common Stock
Cue Biopharma Inc	Pamela D. Garzone	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	21,800	21,800 (0%)	0%		0	Common Stock
Cue Biopharma Inc	Pasha Sarraf	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	21,800	32,595 (0%)	0%		0	Common Stock
Cue Biopharma Inc	Viola Mong Meehan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	21,800	21,800 (0%)	0%		0	Common Stock
Alector Inc	Grace Wong-Sarad	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	20,000	115,461 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Juan Carlos Jaen	President	Sale of securities on an exchange or to another person at price $ 28.61 per share.	09 Jul 2026	19,799	822,508 (1%)	0%	28.6	566,410	Common Stock
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.45 per share.	09 Jul 2026	19,000	27,383 (0%)	0%	8.5	160,550	Common Stock
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	19,000	0	-		-	Stock Option (Right to Buy)
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	17,167	0	-		-	Stock Option (Right to Buy)
BridgeBio Pharma Inc	Jennifer E. Cook	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.75 per share.	09 Jul 2026	17,167	156,972 (0%)	0%	16.7	287,547	Common Stock
BridgeBio Pharma Inc	Andrea John Ellis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	17,167	17,167	-		-	Stock Option (right to buy)
BridgeBio Pharma Inc	Andrea John Ellis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.75 per share.	09 Jul 2026	17,167	39,746 (0%)	0%	16.7	287,547	Common Stock
BridgeBio Pharma Inc	Andrea John Ellis	Director	Sale of securities on an exchange or to another person at price $ 84.00 per share.	09 Jul 2026	17,167	22,579 (0%)	0%	84	1,442,028	Common Stock
Dianthus Therapeutics Inc 10-year high	Ryan Savitz	EVP, CFO & CBO	Sale of securities on an exchange or to another person at price $ 101.24 per share.	09 Jul 2026	15,329	5,566	-	101.2	1,551,908	Common Stock
4D Molecular Therapeutics Inc	David Kirn	Director, See Remarks	Sale of securities on an exchange or to another person at price $ 12.01 per share.	09 Jul 2026	15,283	884,594	-	12.0	183,560	Common Stock
Traws Pharma Inc 10-year low	Jack E. Stover	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	14,150	14,150	-		-	Stock Option (right to buy)
Traws Pharma Inc 10-year low	John H. Leaman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	14,150	14,150	-		-	Stock Option (right to buy)
Traws Pharma Inc 10-year low	Mary Teresa Shoemaker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	14,150	14,150	-		-	Stock Option (right to buy)
Traws Pharma Inc 10-year low	Trafford Clarke	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	14,150	14,150	-		-	Stock Option (right to buy)
Traws Pharma Inc 10-year low	Werner Cautreels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	14,150	14,150	-		-	Stock Option (right to buy)
Dianthus Therapeutics Inc 10-year high	Ryan Savitz	EVP, CFO & CBO	Sale of securities on an exchange or to another person at price $ 100.22 per share.	09 Jul 2026	10,354	20,895	-	100.2	1,037,678	Common Stock
UroGen Pharma Ltd	Mark P. Schoenberg	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 40.00 per share.	09 Jul 2026	10,000	119,763 (0%)	0%	40	400,000	Ordinary Shares
Neurocrine Biosciences Inc	Darin M. Lippoldt	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 179.60 per share.	09 Jul 2026	10,000	54,729 (0%)	0%	179.6	1,796,014	Common Stock
Neurocrine Biosciences Inc	Darin M. Lippoldt	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.49 per share.	09 Jul 2026	10,000	64,729 (0%)	0%	81.5	814,900	Common Stock
Neurocrine Biosciences Inc	Darin M. Lippoldt	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	10,000	4,965	-		-	Non-Qualified Stock Option
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	09 Jul 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	9,500	30,218	-		-	Stock Option
Dianthus Therapeutics Inc 10-year high	Ryan Savitz	EVP, CFO & CBO	Sale of securities on an exchange or to another person at price $ 101.97 per share.	09 Jul 2026	5,566	0	-	102.0	567,565	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 551.03 per share.	09 Jul 2026	2,863	43,722 (0%)	0%	551.0	1,577,611	Common Stock
Twist Bioscience Corp	Adam Laponis	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 94.33 per share.	09 Jul 2026	2,399	110,276 (0%)	0%	94.3	226,307	Common Stock
Mineralys Therapeutics Inc	David Rodman	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share.	09 Jul 2026	2,171	59,904	-	16	34,736	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for Industry - Biotech stocks based on disclosures made from Jul 07, 2026 to Jul 21, 2026

Monitor Industry - Biotech insider transactions and discover insider buying and selling of stocks from Jul 07, 2026 to Jul 21, 2026.

The latest disclosure under SEC insider trading regulations was reported by Elicio Therapeutics Inc.., where the revocation of 186,944 Stock Option (Right to Buy) of common stock was executed . This transaction was reported to the Securities and Exchange Commission on July 16, 2026.

Screeners based on Insider Trading parameters